Silencing NRF2 decreases the self-renewal capacity of glioma stem cells by critically reducing the expression of B lymphoma Mo-MLV insertion region 1 homolog (Bmi1, a transcription regulation factor for stem cells), SRY-box 2 (Sox2, a regulator of growth factors) and Cyclin E [28]. Here, BMI1 is linked to central nervous system cancer.